highlight
epitop
neutral
antibodi
confin
apex
merscov
epitop
rel
well
conserv
igg
fab
neutral
pseudotyp
authent
merscov
neutral
prevent
bind
trimer
protein
brief
wang
et
al
report
structur
function
character
middl
east
respiratori
syndrom
coronaviru
merscov
neutral
antibodi
recogn
conserv
epitop
merscov
ntermin
domain
neutral
merscov
interf
bind
host
receptor
dipeptidyl
find
relev
understand
viral
attach
mechan
develop
vaccin
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
human
popul
caus
substanti
morbid
mortal
potent
neutral
antibodi
target
receptorbind
domain
rbd
merscov
spike
protein
character
much
less
known
antibodi
target
nonrbd
epitop
report
structur
function
character
neutral
antibodi
target
merscov
ntermin
domain
structur
alon
complex
merscov
defin
site
vulner
compris
two
loop
contain
residu
mutat
variant
cellsurfac
bind
studi
vitro
competit
experi
demonstr
strongli
disrupt
attach
merscov
receptor
dipeptidyl
inhibit
requir
nativ
trimer
conform
result
advanc
understand
antibodymedi
neutral
coronavirus
facilit
develop
immunotherapeut
vaccin
merscov
middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
coronaviru
first
identifi
saudi
arabia
zaki
et
al
merscov
caus
sever
acut
respiratori
diseas
human
symptom
includ
fever
cough
short
breath
end
world
health
organ
notifi
laboratoryconfirm
case
merscov
infect
countri
case
occur
middl
east
merscov
casefat
rate
laboratoryconfirm
sever
diseas
number
death
exceed
merscov
like
origin
bat
camel
function
secondari
intermedi
host
azhar
et
al
mohd
et
al
small
cluster
infect
sever
countri
suggest
limit
humantohuman
transmiss
occur
close
contact
ki
oboho
et
al
due
ongo
circul
high
pathogen
capac
interhuman
transmiss
associ
merscov
persist
concern
possibl
pandem
specif
antivir
drug
protect
vaccin
current
avail
effici
countermeasur
viru
urgent
need
surfac
coronaviru
virion
decor
larg
trimer
spike
glycoprotein
mediat
cell
entri
gierer
et
al
li
merscov
glycoprotein
synthes
singlechain
precursor
subsequ
cleav
furinlik
host
proteas
gener
subunit
millet
whittak
matur
protein
homotrim
noncoval
associ
subunit
wherebi
trimer
act
fusionsuppress
cap
sit
atop
trimer
subunit
bind
host
receptor
dipeptidyl
lu
et
al
raj
et
al
wang
et
al
initi
larg
irrevers
conform
chang
mediat
fusion
viral
hostcel
membran
cryoelectron
microscopi
cryoem
structur
variou
bcoronavirus
gui
et
al
kirchdoerf
et
al
pallesen
et
al
shang
et
al
shang
et
al
wall
et
al
wall
et
al
xiong
et
al
yuan
et
al
reveal
fourdomain
architectur
includ
ntermin
domain
ntd
ctermin
domain
ctd
subdomain
ii
function
receptorbind
domain
rbd
depend
specif
coronaviru
bcoronavirus
includ
sever
acut
respiratori
syndromecov
sarscov
li
et
al
li
et
al
merscov
lu
et
al
raj
et
al
wang
et
al
use
bind
function
receptor
wherea
lineag
bcoronavirus
mous
hepat
viru
mhv
peng
et
al
bovin
coronaviru
bcov
peng
et
al
bind
receptor
use
prefus
protein
coronavirus
includ
human
coronaviru
kirchdoerf
et
al
mhv
wall
et
al
fold
wellpack
symmetr
trimer
ntd
ctd
tightli
interact
conform
receptorbind
surfac
ctd
mostli
occlud
within
intern
surfac
trimer
convers
prefus
sarscov
gui
et
al
yuan
et
al
merscov
pallesen
et
al
yuan
et
al
protein
adopt
dynam
open
close
conform
wherein
three
adopt
either
compact
conform
buri
receptorbind
surfac
conform
facilit
bind
hostcel
receptor
hypothes
conform
exist
equilibrium
receptor
bind
conform
result
three
ctd
arrang
unstabl
result
dissoci
refold
gui
et
al
pallesen
et
al
song
et
al
wall
et
al
yuan
et
al
coronaviru
adopt
threelay
structur
core
region
form
galectinlik
b
sandwich
fold
top
region
core
commonli
use
lineag
bcoronavirus
bind
protein
glycan
receptor
bottom
conserv
region
stretch
connect
peng
et
al
structur
merscov
report
previous
pallesen
et
al
yuan
et
al
specif
interact
hostcel
factor
well
character
recent
studi
suggest
chan
et
al
chu
et
al
sialic
acid
may
serv
import
attach
factor
prior
bind
interact
may
mediat
main
protein
surfac
coronaviru
virion
protein
key
target
protect
antibodi
respons
li
modjarrad
et
al
mani
neutral
antibodi
target
merscov
rbd
isol
character
corti
et
al
jiang
et
al
li
et
al
tang
et
al
ying
et
al
structur
studi
reveal
epitop
overlap
surfac
therebi
provid
structur
basi
neutral
besid
immunodomin
rbd
also
shown
induc
protect
antibodi
respons
mous
model
jiam
et
al
neutral
antibodi
target
merscov
report
includ
human
antibodi
murin
antibodi
macaqu
antibodi
wang
et
al
wang
et
al
antibodi
potent
broad
neutral
potenti
array
merscov
strain
addit
ntdspecif
merscov
antibodi
shown
confer
protect
lethal
challeng
anim
model
howev
lack
structur
inform
hinder
definit
epitop
determin
mechan
action
address
knowledg
gap
initi
seri
comprehens
studi
report
crystal
structur
fab
alon
bound
merscov
well
result
biochem
biophys
cellbas
assay
studi
defin
site
vulner
merscov
spike
elucid
mechan
neutral
involv
inhibit
attach
epitop
confin
sole
conduct
surfac
plasmon
reson
spr
experi
character
interact
fab
merscov
figur
well
interact
fab
prefusionstabil
merscov
ectodomain
merscov
pallesen
et
al
figur
affin
fab
merscov
similar
k
nm
respect
bind
kinet
also
good
agreement
indic
epitop
confin
precis
local
epitop
perform
vitro
select
variant
serial
passag
recombin
merscov
strain
vero
cell
cultur
scobey
et
al
supplement
progress
escal
concentr
immunoglobulin
g
igg
passag
merscov
isol
plaqu
clone
mutat
analyz
clone
contain
either
substitut
tabl
suggest
two
residu
crucial
bind
test
hypothesi
gener
merscov
variant
harbor
substitut
spr
measur
reveal
substitut
complet
abolish
bind
fab
concentr
test
figur
next
gener
pseudotyp
lentivirus
bear
mutant
merscov
glycoprotein
assess
effect
substitut
neutral
activ
igg
expect
igg
potent
neutral
pseudovirus
bear
wildtyp
wt
protein
wherea
igg
poorli
neutral
pseudovirus
harbor
escap
mutat
maximum
neutral
fraction
figur
addit
verifi
neutral
abil
igg
recombin
merscov
strain
n
et
al
variant
biosafeti
level
set
igg
neutral
authent
merscov
ec
nm
wherea
abil
igg
neutral
variant
bare
detect
rais
concentr
mm
figur
result
indic
epitop
local
surfac
near
residu
epitop
primarili
local
two
loop
top
precis
defin
epitop
determin
crystal
structur
fab
alon
complex
merscov
fab
form
crystal
space
group
diffract
xray
resolut
phase
molecular
replac
reveal
four
fab
molecul
per
asymmetr
unit
iter
round
model
build
refin
final
model
rr
free
tabl
crystal
fab
complex
prove
difficult
necessit
explor
differ
express
purif
strategi
ultim
crystal
complex
obtain
space
group
diffract
xray
resolut
molecular
replac
solut
contain
two
molecul
complex
per
asymmetr
unit
iter
round
model
build
refin
produc
final
model
rr
free
structur
merscov
similar
coronavirus
separ
top
core
bottom
region
figur
merscov
core
contain
b
sandwich
structur
form
two
b
sheet
contain
total
b
strand
figur
label
provid
scaffold
support
top
bottom
region
stretch
loop
residu
design
spiral
perpendicularli
b
sheet
like
righthand
pseudohelix
compris
major
bind
interfac
disulfid
bond
connect
ntermin
loop
residu
design
contribut
remain
bind
interfac
figur
four
six
complementaritydetermin
region
involv
bind
figur
interact
wherea
heavychain
cdr
interact
except
one
hydrogen
bond
form
residu
residu
heavychain
residu
form
hydrogen
bond
mainchain
atom
wherea
heavychain
residu
interact
side
chain
residu
respect
interact
light
chain
mediat
three
residu
two
residu
residu
form
two
salt
bridg
wherea
form
hydrogen
bond
mainchain
atom
residu
eight
nlink
glycosyl
site
within
crystal
protein
treat
glycosidas
electron
densiti
larg
glycan
moieti
observ
sever
glycosyl
site
howev
none
glycosyl
site
within
bind
interfac
figur
thu
unlik
bind
depend
presenc
nlink
glycan
verifi
spr
studi
confirm
deglycosyl
retain
similar
affin
glycosyl
figur
structur
consist
data
show
merscov
cultur
select
accumul
substitut
bind
interfac
tabl
base
structur
predict
substitut
would
larg
elimin
hydrophil
interact
substitut
would
introduc
long
side
chain
lead
steric
clash
would
impair
interact
addit
two
escap
mutat
probe
interfac
introduc
singl
mutat
expect
structur
either
two
substitut
larg
abolish
bind
fab
figur
previou
neutral
data
demonstr
igg
neutral
pseudovirus
protein
eight
differ
merscov
strain
inhibitori
concentr
ic
valu
rang
mgml
contrast
antibodi
like
show
weaker
neutral
potenc
analyz
sequenc
eight
test
strain
identifi
amino
acid
differ
seven
posit
howev
none
involv
interact
figur
addit
analyz
avail
merscov
sequenc
genbank
residu
includ
conserv
among
sequenc
explain
igg
broadli
neutral
merscov
strain
interestingli
find
merscov
strain
substitut
figur
two
residu
substitut
escap
variant
vitro
select
eight
sequenc
isol
camel
yusof
et
al
along
one
sequenc
isol
patient
assiri
et
al
harbor
substitut
one
human
merscov
sequenc
isol
drosten
et
al
one
harbor
mutat
test
construct
bear
substitut
bind
fab
affin
lower
compar
affin
wt
figur
natur
occurr
may
indic
merscov
select
pressur
exert
host
antibodi
respons
figur
structur
fab
complex
merscov
overal
structur
complex
heavi
light
chain
color
dark
blue
white
respect
separ
top
red
core
orang
bottom
yellow
region
residu
shown
semitranspar
molecular
surfac
b
structur
top
region
present
ribbon
represent
b
strand
core
region
label
disulfid
bond
drawn
yellow
stick
c
structur
top
region
present
molecular
surfac
view
orient
b
surfac
buri
interfac
encircl
dot
line
residu
form
hydrogen
bond
color
white
blue
respect
contact
two
loop
top
region
antibodi
complementaritydetermin
region
cdr
involv
bind
label
residu
contribut
interact
shown
stick
represent
hydrogen
bond
salt
bridg
depict
black
dot
line
e
linear
sequenc
residu
make
hydrogen
bond
denot
symbol
two
mutat
natur
occur
protein
two
differ
merscov
strain
respect
color
red
investig
bind
context
merscov
trimer
purifi
merscov
ectodomain
complex
fab
perform
negativestain
em
analysi
classif
suggest
sampl
heterogen
postfus
rodlik
particl
abund
figur
suggest
fab
abl
prevent
prefusiontopostfus
transform
ectodomain
solut
gener
resolut
reconstruct
fab
crystal
structur
superimpos
onto
prefus
merscov
structur
pdb
gener
model
fit
well
reconstruct
figur
indic
fab
bind
induc
substanti
conform
chang
merscov
trimer
note
densiti
rbd
miss
due
intrins
dynam
rbd
gui
et
al
pallesen
et
al
yuan
et
al
investig
interact
merscov
trimer
determin
cryoem
structur
merscov
fab
complex
figur
tabl
merscov
ntd
resid
peripheri
trimer
flare
approxim
axi
interfac
situat
apex
protein
bind
fab
elong
axi
form
three
leg
invert
tripod
structur
tilt
toward
axi
figur
distanc
two
bound
fab
bind
interfac
distal
end
fab
figur
substanti
conform
chang
trimer
result
bind
bind
fab
apex
spike
interact
hostcel
factor
occur
suggest
igg
may
interfer
attach
step
cell
entri
test
hypothesi
perform
cellsurfac
bind
assay
shown
figur
gfplabel
merscov
strongli
bound
cell
bind
substanti
reduc
preincub
merscov
molar
excess
igg
rbdspecif
antibodi
interestingli
reduc
merscov
bind
even
though
similar
neutral
potenc
merscov
variant
substitut
bound
cell
level
similar
observ
wt
merscov
howev
contrast
wt
merscov
two
variant
insensit
igg
maintain
highlevel
cellsurfac
bind
even
presenc
excess
igg
collect
data
demonstr
igg
prevent
attach
merscov
cell
express
bind
merscov
requir
rbd
rotat
upward
expos
receptor
bind
surfac
figur
presum
antibodi
block
receptorbind
process
inhibit
rbd
movement
attach
gain
insight
mechan
attach
inhibit
normal
bind
effici
gfptag
merscov
protein
freestyl
cell
presenc
absenc
igg
calcul
median
fluoresc
intens
mfi
valu
freestyl
cell
transfect
plasmid
encod
fulllength
h
experi
nontransfect
cell
nt
incub
merscov
well
transfect
cell
incub
pb
use
neg
control
irrelev
rsv
fspecif
neutral
antibodi
use
anoth
neg
control
bar
graph
show
mean
error
bar
indic
standard
deviat
n
biolog
independ
experi
two
technic
replic
superimpos
onto
merscov
structur
use
fab
structur
present
previous
determin
structur
lu
et
al
wang
et
al
surprisingli
structur
model
indic
fab
would
prevent
movement
rbd
steric
clash
figur
howev
steric
clash
would
predict
occur
merscov
hostcel
membran
igg
bound
figur
bival
igg
could
also
possibl
crosslink
two
adjac
merscov
trimer
result
restrict
access
determin
whether
fab
rather
larger
igg
suffici
activ
bind
inhibit
neutral
abil
fab
evalu
consist
previou
data
rosen
et
al
igg
display
strong
inhibit
solubl
merscov
bind
cell
ic
nm
figur
well
strong
neutral
merscov
scontain
pseudovirus
ic
nm
figur
fab
also
inhibit
cell
bind
ic
nm
figur
neutral
merscov
scontain
pseudovirus
ic
nm
although
well
igg
figur
fab
also
neutral
authent
merscov
dosedepend
manner
observ
pseudovirus
neutral
activ
fab
strong
igg
figur
base
data
conclud
fab
suffici
neutral
block
attach
merscov
cell
like
clash
restrict
exposur
rbd
although
possibl
contribut
cellsurfac
attach
process
directli
bind
one
attach
factor
rbd
play
predomin
role
event
strongli
bind
function
receptor
hypothes
block
cellsurfac
attach
indirectli
inhibit
interact
test
investig
cellsurfac
bind
solubl
membraneanchor
merscov
fulllength
swt
swtfl
fulllength
presenc
absenc
excess
fab
observ
bound
well
cell
transfect
three
protein
construct
figur
expect
posit
antibodi
control
rbdspecif
fab
strongli
inhibit
bind
transfect
cell
directli
compet
rbd
bind
neg
antibodi
control
fab
pallesen
et
al
wang
et
al
exhibit
bind
inhibit
fab
test
differ
bindinginhibit
pattern
observ
fab
prevent
bind
cell
express
trimer
fulllength
swt
allow
bind
cell
express
membraneteth
form
predict
monomer
figur
data
indic
bind
inhibit
fab
depend
intact
trimer
conform
protein
exclud
possibl
unknown
cellsurfac
factor
may
play
role
inhibit
bind
merscov
trimer
perform
spr
competit
assay
use
purifi
protein
figur
captur
onto
spr
chip
flow
merscov
protein
merscov
protein
supplement
molar
excess
differ
fab
merscov
absenc
fab
bound
well
captur
black
curv
merscov
supplement
rbdspecif
fab
display
bind
blue
curv
confirm
strong
competit
fab
bind
rbd
merscov
supplement
fab
display
higher
respons
curv
merscov
alon
due
ad
mass
bound
fab
lack
bind
inhibit
merscov
supplement
fab
display
substanti
lower
bind
captur
either
merscov
supplement
fab
merscov
alon
purpl
curv
confirm
interfer
bind
trimer
merscov
igg
reduc
bind
merscov
even
red
curv
despit
increas
mass
igg
compar
fab
unlik
fab
neither
fab
igg
block
bind
complet
suggest
use
indirect
mechan
inhibit
around
differ
monoclon
antibodi
isol
neutral
merscov
major
target
rbd
except
antibodi
nonrbddirect
merscov
neutral
antibodi
isol
specif
includ
mice
macaqu
human
wang
et
al
wang
et
al
neutral
antibodi
also
isol
sarscov
coughlin
et
al
greenough
et
al
rockx
et
al
includ
thu
sarscov
merscov
common
site
antibodi
vulner
despit
lack
structur
character
studi
antibodi
provid
insight
neutral
mechan
antibodi
shown
bind
sar
fragment
residu
coughlin
et
al
effici
prevent
viral
entri
ad
bind
pseudoviru
onto
target
cell
suggest
like
neutral
disrupt
postbind
event
instead
interf
cell
attach
process
also
note
anoth
merscov
neutral
antibodi
compet
indic
recogn
differ
epitop
thu
like
antibodi
neutral
differ
mechan
molecular
mechan
regul
receptor
bind
fusion
activ
coronaviru
spike
protein
current
subject
activ
investig
field
recent
studi
demonstr
receptor
bind
proteolyt
cleavag
requir
shed
allow
refold
postfus
state
song
et
al
wall
et
al
data
suggest
may
play
role
regul
fine
tune
process
although
molecular
detail
remain
unknown
upon
bind
ntd
larg
bival
igg
would
abl
gener
barrier
virushost
interfac
prevent
attach
figur
short
stalk
restrict
movement
access
rbd
protein
reason
explain
neutral
abil
exert
igg
howev
demonstr
fab
also
prevent
bind
merscov
trimer
despit
predict
steric
clash
fab
cellsurfac
figur
also
demonstr
fab
abil
prevent
attach
solubl
cellsurfac
trimer
figur
feel
unlik
reduc
bind
attribut
steric
interfer
may
cross
talk
rbd
within
trimer
bind
ntd
reduc
exposur
rbd
receptoraccess
conform
previou
studi
identifi
sarscov
peptid
residu
design
peptid
inhibit
sarscov
smediat
entri
dosedepend
manner
guo
et
al
peptid
map
onto
cryoem
structur
sarscov
trimer
local
interfac
suggest
figur
comparison
top
region
merscov
bcov
mhv
color
figur
depict
ribbon
represent
top
middl
row
residu
interact
fab
sialic
acid
shown
blue
sphere
merscov
bcov
mhv
structur
respect
topolog
model
shown
bottom
row
b
sheet
depict
arrow
helic
depict
red
cylind
bind
surfac
describ
denot
blue
oval
figur
made
base
structur
merscov
fab
describ
paper
bcov
peng
et
al
hibit
mediat
interf
interact
rbd
adjac
protom
data
vitro
competit
assay
demonstr
fab
indirectli
prevent
interact
absenc
attach
factor
coreceptor
howev
sever
merscov
attach
factor
identifi
includ
chan
et
al
sialic
acid
chu
et
al
sever
coronavirus
demonstr
use
bind
glycan
bind
function
protein
receptor
li
case
tgev
porcin
coronaviru
sialic
acid
bind
highli
relat
enteropathogen
krempl
et
al
bcov
peng
et
al
schultz
et
al
unkel
herrler
also
use
sialic
acid
receptor
sugarbind
pocket
locat
top
region
mhv
anoth
bcoronaviru
use
top
region
bind
protein
receptor
peng
et
al
interestingli
although
bcov
mhv
spike
bind
differ
host
receptor
bind
surfac
similarli
present
figur
loop
stretch
contribut
bind
surfac
antibodi
may
therefor
directli
block
receptor
interact
coronavirus
mention
numer
neutral
antibodi
isol
mice
nonhuman
primat
nhp
merscov
patient
wang
et
al
wang
et
al
indic
immunogen
recent
studi
test
directli
use
merscov
fragment
immunogen
result
reveal
induc
robust
protect
antibodi
respons
mous
model
jiam
et
al
studi
defin
site
vulner
may
import
structurebas
vaccin
design
futur
effort
may
improv
immunogen
expos
vulner
site
mask
elimin
nonneutr
epitop
normal
buri
prefus
spike
strategi
alreadi
success
use
rbdbase
vaccin
design
du
et
al
wherein
introduct
glycosyl
site
nonneutr
epitop
led
engin
rbd
immunogen
significantli
efficaci
mous
model
merscov
challeng
detail
method
provid
onlin
version
paper
includ
follow
thank
colleagu
member
lab
comment
manuscript
emili
shipman
dartmouth
colleg
john
ludesmey
utaustin
assist
protein
express
beamlin
scientist
xray
data
collect
support
sbc
argonn
nation
laboratori
xiaotao
lu
vanderbilt
mutant
viru
construct
use
merscov
bac
erica
andr
vanderbilt
xiaotao
lu
assist
select
sequenc
analysi
escapemut
virus
gabriel
ozorowski
assist
cryoem
model
build
refin
conway
p
tyka
md
dimaio
f
konerd
de
baker
relax
backbon
bond
geometri
improv
protein
energi
landscap
model
protein
sci
corti
zhao
j
pedotti
simonelli
l
agnihothram
fett
c
fernandezrodriguez
b
foglierini
agat
g
vanzetta
f
et
al
prophylact
postexposur
efficaci
potent
human
monoclon
antibodi
mer
coronaviru
proc
natl
acad
sci
usa
coughlin
mm
babcook
j
prabhakar
bs
human
monoclon
antibodi
sarscoronaviru
inhibit
infect
differ
mechan
virolog
drosten
c
muth
corman
vm
hussain
r
al
masri
hajomar
w
landt
assiri
eckerl
al
shangiti
et
al
observ
laboratorybas
studi
outbreak
middl
east
respiratori
syndrom
coronaviru
jeddah
riyadh
kingdom
saudi
arabia
clin
infect
di
du
l
tai
w
yang
zhao
g
zhu
q
sun
liu
c
tao
x
tseng
ck
perlman
et
al
introduct
neutral
immunogen
index
ration
design
mer
coronaviru
subunit
vaccin
nat
commun
emsley
p
cowtan
k
inform
request
resourc
reagent
direct
fulfil
lead
contact
jason
mclellan
jmclellan
austinutexasedu
reagent
gener
studi
avail
via
materi
transfer
agreement
mta
freestyl
cell
cell
purchas
thermofish
scientif
use
express
protein
fab
igg
maintain
follow
compani
protocol
vero
cell
obtain
atcc
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
uml
penicillin
mgml
streptomycin
mgml
amphotericin
b
humidifi
c
incub
contain
co
use
vitro
select
variant
plaquereduct
neutral
assay
cell
obtain
atcc
cultur
dmem
heatinactiv
fetal
bovin
serum
hifb
penicillinstreptomycin
c
incub
contain
co
use
produc
merscov
pseudovirus
cell
obtain
atcc
cultur
dmem
medium
hifb
penicillinstreptomycin
c
incub
contain
co
cell
provid
dr
deborah
r
taylor
us
fda
cultur
dmem
hifb
penicillin
streptomycin
c
incub
contain
co
cell
use
neutral
assay
differ
experi
recombin
merscov
strain
scobey
et
al
use
select
variant
plaquereduct
neutral
test
recombin
wildtyp
spike
mutant
merscov
recov
bacteri
artifici
chromosom
bac
contain
fulllength
isol
genom
n
et
al
gift
dr
stanley
perlman
univers
iowa
spike
mutat
aros
passag
select
merscov
resist
neutral
introduc
merscov
bac
use
publish
protocol
fehr
et
al
complet
gene
sequenc
recombin
viru
determin
confirm
accuraci
mutagenesi
select
analysi
variant
stock
recombin
merscov
recov
infecti
clone
scobey
et
al
serial
passag
vero
cell
supplement
increas
concentr
three
parallel
passag
seri
perform
passag
initi
multipl
infect
moi
pfu
per
cell
concentr
mgml
correspond
versu
merscov
plaquereduct
neutral
assay
cultur
supernat
pass
onto
fresh
cell
monolay
display
viral
cpe
viral
inoculum
volum
concentr
empir
coadjust
passag
step
produc
target
cpe
level
approxim
hourspostinfect
hpi
concentr
termin
passag
mgml
correspond
clonal
escap
mutant
virus
five
passag
isol
cultur
via
plaqu
purif
vero
cell
presenc
mgml
viral
plaqu
expand
vero
cell
total
rna
harvest
trizol
reagent
invitrogen
follow
rtpcr
gener
overlap
cdna
amplicon
span
entir
gene
open
read
frame
pcr
product
subject
dideoxi
sequenc
read
align
nativ
gene
sequenc
genbank
access
number
identifi
differ
separ
viru
passag
experi
three
parallel
lineag
antibodyfre
cultur
examin
mutat
identifi
cell
cultureadapt
chang
result
serial
merscov
passag
substitut
exclud
analysi
chang
identifi
escap
mutant
isol
wildtyp
spike
mutant
merscov
recov
bacteri
artifici
chromosom
bac
contain
fulllength
emc
isol
genom
n
et
al
gift
dr
stanley
perlman
univers
iowa
spike
mutat
aros
passag
select
merscov
resist
neutral
introduc
merscov
bac
use
publish
protocol
fehr
et
al
complet
gene
sequenc
recombin
viru
determin
confirm
accuraci
mutagenesi
serial
dilut
igg
fab
combin
approxim
pfu
wt
mutant
merscov
total
volum
ml
gelatin
salin
wtvol
gelatin
phosphatebuff
salin
supplement
cacl
mgcl
virusantibodi
mixtur
incub
min
c
follow
adsorpt
ml
aliquot
two
confluent
well
vero
cell
plate
min
c
monolay
overlaid
dulbecco
modifi
eagl
medium
dmem
contain
agar
plaqu
enumer
h
postinfect
percent
neutral
calcul
averag
plaqu
produc
iggor
fabtreat
viru
divid
averag
plaqu
produc
viru
antibodyfre
gelatin
salin
substitut
introduc
via
pcr
plasmid
encod
fulllength
spike
merscov
afi
scontain
lentivir
pseudovirion
produc
cotransfect
three
plasmid
packag
plasmid
transduc
plasmid
phr
cmvluc
cmvrmerscov
plasmid
cell
use
fugen
transfect
reagent
promega
madison
wi
naldini
et
al
neutral
assay
cell
provid
deborah
r
taylor
us
fda
plate
whiteblack
isopl
perkinelm
waltham
cellswel
day
infect
serial
dilut
monoclon
antibodi
mix
titrat
pseudoviru
incub
min
c
ad
cell
triplic
follow
h
incub
well
replenish
ml
fresh
medium
cell
lyse
h
later
luciferas
activ
measur
percent
neutral
calcul
luminometri
data
fab
region
heavi
chain
fuse
cleavag
site
follow
human
fc
fragment
subclon
eukaryot
express
vector
plasmid
plasmid
cotransfect
vector
encod
light
chain
plasmid
cell
invitrogen
secret
antibodi
purifi
use
protein
agaros
fisher
proteas
wtwt
ad
protein
reaction
incub
h
room
temperatur
digest
antibodi
pass
back
protein
agaros
remov
fc
fragment
unbound
fab
addit
purifi
use
superdex
column
ge
healthcar
neutral
assay
compar
igg
versu
fab
merscov
strain
pseudovirion
express
wildtyp
mutant
protein
produc
cotransfect
three
plasmid
cell
use
fugen
transfect
reagent
promega
madison
wi
titer
describ
previous
neutral
assay
cell
exogen
express
use
previous
describ
briefli
express
cell
two
day
posttransfect
antibodi
mix
merscov
pseudovirus
ad
cell
hour
later
cell
lyse
analyz
luciferas
activ
rel
luciferas
unit
measur
percent
neutral
calcul
consid
uninfect
cell
neutral
cell
transduc
pseudoviru
neutral
biacor
ge
healthcar
use
measur
bind
untag
merscov
presenc
molar
excess
igg
fabto
immobil
twinstreptag
ectodomain
captur
use
antistrep
antibodycoupl
chip
total
respons
unit
chip
regener
cycl
use
mm
glycin
ph
follow
sd
hbsp
ph
use
run
buffer
well
sampl
buffer
cycl
hb
p
ph
inject
immobil
clean
chip
follow
inject
buffer
nm
fab
igg
nm
nm
supplement
nm
fab
igg
experi
perform
c
data
referencesubtract
analyz
biaevalu
softwar
bind
neutral
assay
conduct
least
duplic
measur
present
mean
sem
indic
number
replic
detail
found
figur
legend
coordin
structur
factor
fab
deposit
protein
data
bank
access
code
pdb
coordin
structur
factor
merscov
fab
deposit
protein
data
bank
access
code
pdb
cryoem
reconstruct
fab
complex
deposit
electron
microscopi
data
bank
emdb
access
code
emdb
atom
model
deposit
protein
data
bank
pdb
